These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 18766151)

  • 1. In search of a treatment for Alzheimer's disease and potential immunonosuppresive therapeutic interventions.
    Dhawan N; Puangco J; Jandial R
    Neuro Endocrinol Lett; 2008 Aug; 29(4):410-20. PubMed ID: 18766151
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Microglia as a potential bridge between the amyloid beta-peptide and tau.
    Kitazawa M; Yamasaki TR; LaFerla FM
    Ann N Y Acad Sci; 2004 Dec; 1035():85-103. PubMed ID: 15681802
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Microglial interaction with beta-amyloid: implications for the pathogenesis of Alzheimer's disease.
    Bamberger ME; Landreth GE
    Microsc Res Tech; 2001 Jul; 54(2):59-70. PubMed ID: 11455613
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Therapy of Alzheimer disease].
    Kovács T
    Neuropsychopharmacol Hung; 2009 Mar; 11(1):27-33. PubMed ID: 19731816
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Fundamental data on the pathologies amyloid and Tau in Alzheimer's disease: which therapeutic perspectives?].
    Checler F; Buée L
    Ann Pharm Fr; 2009 Mar; 67(2):136-53. PubMed ID: 19298897
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of inflammation in Alzheimer's disease.
    Tuppo EE; Arias HR
    Int J Biochem Cell Biol; 2005 Feb; 37(2):289-305. PubMed ID: 15474976
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical aspects of inflammation in Alzheimer's disease.
    Rosenberg PB
    Int Rev Psychiatry; 2005 Dec; 17(6):503-14. PubMed ID: 16401549
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Progress in Alzheimer's disease drug discovery: an update.
    Williams M
    Curr Opin Investig Drugs; 2009 Jan; 10(1):23-34. PubMed ID: 19127484
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inflammation and Alzheimer's disease.
    Gupta A; Pansari K
    Int J Clin Pract; 2003; 57(1):36-9. PubMed ID: 12587940
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inflammatory processes in Alzheimer's disease.
    McGeer EG; McGeer PL
    Prog Neuropsychopharmacol Biol Psychiatry; 2003 Aug; 27(5):741-9. PubMed ID: 12921904
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic options in Alzheimer's disease.
    Moreira PI; Zhu X; Nunomura A; Smith MA; Perry G
    Expert Rev Neurother; 2006 Jun; 6(6):897-910. PubMed ID: 16784412
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Inflammation and Alzheimer's disease].
    de Toledo M
    Rev Neurol; 2006 Apr 1-15; 42(7):433-8. PubMed ID: 16602061
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current approaches in the treatment of Alzheimer's disease.
    Shah RS; Lee HG; Xiongwei Z; Perry G; Smith MA; Castellani RJ
    Biomed Pharmacother; 2008; 62(4):199-207. PubMed ID: 18407457
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activity of flurbiprofen and chemically related anti-inflammatory drugs in models of Alzheimer's disease.
    Gasparini L; Ongini E; Wilcock D; Morgan D
    Brain Res Brain Res Rev; 2005 Apr; 48(2):400-8. PubMed ID: 15850679
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Alzheimer's disease: from brain lesions to new drugs].
    Forette F; Hauw JJ
    Bull Acad Natl Med; 2008 Feb; 192(2):363-78; discussion 378-80. PubMed ID: 18819689
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High dietary consumption of trans fatty acids decreases brain docosahexaenoic acid but does not alter amyloid-beta and tau pathologies in the 3xTg-AD model of Alzheimer's disease.
    Phivilay A; Julien C; Tremblay C; Berthiaume L; Julien P; Giguère Y; Calon F
    Neuroscience; 2009 Mar; 159(1):296-307. PubMed ID: 19135506
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potential immunotargets for Alzheimer's disease treatment strategies.
    Fernández PL; Britton GB; Rao KS
    J Alzheimers Dis; 2013; 33(2):297-312. PubMed ID: 23001712
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inflammation and Alzheimer's disease: relationships between pathogenic mechanisms and clinical expression.
    Eikelenboom P; Rozemuller JM; van Muiswinkel FL
    Exp Neurol; 1998 Nov; 154(1):89-98. PubMed ID: 9875271
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuropathology in Alzheimer's disease: target of pharmacotherapy.
    Souder E
    J Am Acad Nurse Pract; 2005 Mar; Suppl():3-5. PubMed ID: 16033022
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Innate immunity, local inflammation, and degenerative disease.
    McGeer PL; McGeer EG
    Sci Aging Knowledge Environ; 2002 Jul; 2002(29):re3. PubMed ID: 14602998
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.